Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies

Given the widespread introduction of tyrosine kinase inhibitors (TKIs), we evaluated the cost associated with chronic myelogenous leukemia (CML) care compared with the cost of care for patients with hematologic malignancies (HEM) and for patients without cancer (GEN), to aid with resource allocation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Oncol Pract
Main Authors: Wilkes, Jennifer J., Lyman, Gary H., Doody, David R., Chennupati, Shasank, Becker, Laura K., Morin, Pamela E., Winestone, Lena E., Henk, Henry J., Chow, Eric J.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
ORIGINAL CONTRIBUTIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189599/
https://ncbi.nlm.nih.gov/pubmed/32822255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/OP.20.00143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados